‘Microdosing’ psychedelics involves taking small, repeated doses of a psychedelic drug. Researcher Robin Murphy talks us through the latest Auckland University microdosing study.
Well-known NZers share what it's like to live without alcohol in a culture that celebrates it at every turn
Executive Director Sarah Helm reflects on this year's global drug conference
As harm reduction advocates in Aotearoa push for better naloxone access, we look for lessons across the ditch.
Given MDMA’s popularity, potential therapeutic uses, and low harm profile, is it time we re-examine how we regulate it here? Drug Foundation Senior Communications Advisor Feilidh Dwyer investigates.
In Aotearoa, scientists, iwi, as well as hobbyists and amateurs are busy researching what psilocybin’s potential could be. So, what’s next for psilocybin in Aotearoa?
Russell Brown takes a look at how Australia's recent move to allow psilocybin and MDMA for prescription would work in practice, and whether a similar shift could be possible in New Zealand.
Commentator Russell Brown takes a look at the ACT's road to decriminalising drug possession, and asks what New Zealand could learn.
Drug Foundation Communications Advisor Feilidh Dwyer visits a thought-provoking MDMA pop-up shop in Utrecht.
Today, the Drug Foundation and the Helen Clark Foundation released a new paper: Minimising the Harms from Methamphetamine. The Drug Foundation's Executive Director, Sarah Helm, breaks down the findings.
Chris Fowlie takes a look at who will be most affected by New Zealand's new drug driving laws, and how.
Some people are still mistrustful about the legal status of drug checking. We asked Leah Rothman to clear up some of the confusion.